AI assistant
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2024
May 21, 2024
35599_dirs_2024-05-21_1a5c9b11-7597-442a-abfa-6a2808523084.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2024-05-16
Reporting Person: Raykov Rosty (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-16 | Stock Option | $7.12 | A | 200000 | Acquired | 2034-05-16 | Common shares (200000) | Direct |
| 2024-05-16 | Restricted Share Unit | $0 | A | 100000 | Acquired | 2034-05-16 | Common shares (100000) | Direct |
Footnotes
F1: On May 16, 2024, Rostislav Raykov was granted incentive stock options to purchase 200,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2: 1/3 of the shares subject to this grant shall vest as of May 16, 2025 (the "Vesting Commencement Date"). 1/24 of the grant shall vest as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this grant shall be vested.
F3: 1. On May 16, 2024, Rostislav Raykov was awarded restricted share units to receive 100,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F4: 1/3 of the shares subject to this award shall be released from restriction as of May 16, 2025 (the "Vesting Commencement Date"). 1/24 of the award shall be released from restriction as of the last day of each month following the Vesting Commencement Date. As of April 30, 2027 and thereafter, 100% of the total number of shares subject to this award shall be released.